---
schema_version: "secwatch.filing_event.v1"
accession: "0001127537-25-000058"
form_type: "8-K"
ticker: "LUNG"
cik: "0001127537"
company_name: "Pulmonx Corp"
filed_at: "2025-11-12T23:59:59+00:00"
generated_at: "2026-05-16T20:53:55.662895+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Pulmonx Q3 rev $21.5M (+5%), net loss $14.0M; guides FY rev $89-90M; adds COO role

## Summary
- Worldwide revenue $21.5M (+5% YoY); US $14.0M (+1%), Intl $7.5M (+15%).
- Gross margin 75% vs 74% YoY; net loss $14.0M ($0.34/share) vs $14.1M ($0.36) YoY.
- Adjusted EBITDA loss $8.2M vs $8.1M YoY; cash $76.5M.
- FY2025 revenue guidance narrowed to $89-90M; operating expenses $125-126M incl ~$21M SBC.
- Glen French reappointed CEO; Derrick Sung appointed COO & CFO.

## SEC filing metadata
- accession: 0001127537-25-000058
- form_type: 8-K
- ticker: LUNG
- cik: 0001127537
- company_name: Pulmonx Corp
- filed_at: 2025-11-12T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1127537/000112753725000058/0001127537-25-000058-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1127537/000112753725000058/lung-20251112.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001127537-25-000058
- JSON: https://secwatch.observer/filing/0001127537-25-000058.json
- Plain text: https://secwatch.observer/filing/0001127537-25-000058.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.